Study on diagnostic significance of gastrointestinal tumor markers in patients with pancreatic cancer

王婧,李卉惠,车娟娟,马妮娜,庞慧,曹邦伟

DOI: https://doi.org/10.3969/j.issn.1671-4695.2014.13.003

2014-01-01

Abstract:Objective To explore the clinical diagnostic significance of serum CA19 - 9,CEA,CA125,CA724 and CA50 in patients with malignant tumors of digestive system. Methods Serum levels of CA19 - 9,CEA,CA125,CA724 and CA50 were detected by Abbott AR-CHITECT i2000 from 18 patients with pancreatic cancer,35 patients with pancreatic benign diseases(20 patients with post - pancreatic operation and 15 patients with acute pancreatitis)and 14 healthy controls. Results Serum levels of CA19 - 9,CA125 and CEA were significantly higher in pancreatic cancer group than those of benign pancreatic disease group,while serum level of CA19 - 9 was the highest(646. 33 ± 124. 15 ug/ ml). In comparison with healthy controls,serum levels of CA19 - 9,CEA and CA724 were increased in patients with benign pancreatic diseases,and the difference was statistically significant( P ﹤ 0. 05). There was no difference in serum level of CA724 among these three groups. The sensitivity of CA19 - 9 was 77. 8% ,its specificity was 83. 7% and accuracy was 79. 1% . The sensitivity and specificity of combined detection of CA19 - 9 and CA125 were 100% and 79. 6% respectively,and its rate of accuracy was 85. 1% . Conclusion Serum levels of CAl99,CEA and CA125 have clinical significance in diagnosis of patients with pancreatic cancer,and the combined detection of tumor markers can raise the diagnostic rate of pancreatic cancer.